17 articles for W Hou
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Pharmacological activity and mechanism of pyrazines.

Gannan Medical University
Diselenide Covalent Allosteric Inhibitors of Glutaminase with Strong

Zhejiang University
Celastrol: Progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology.

Zhejiang University
Advances of CCR5 antagonists: From small molecules to macromolecules.

Chengdu University
Synthesis of Novel Kidney-Type Glutaminase Allosteric Inhibitors Targeting the Critical Lys-320 Residue.

Zhejiang University
Novel PHD2/HDACs hybrid inhibitors protect against cisplatin-induced acute kidney injury.

Peking Union Medical College
Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors.

Peking Union Medical College
Structure-based design, synthesis, and evaluation of inhibitors with high selectivity for PARP-1 over PARP-2.

Shenyang Pharmaceutical University
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.

Peking Union Medical College
Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors.

Beijing Normal University
Identification and Optimization of Novel Cathepsin C Inhibitors Derived from EGFR Inhibitors.

National Institute of Biological Sciences (Nibs)
Novel 1,3,4-Selenadiazole-Containing Kidney-Type Glutaminase Inhibitors Showed Improved Cellular Uptake and Antitumor Activity.

Zhejiang University
Design and synthesis of biotinylated Hexylselen as a probe to identify KGA allosteric inhibitors by a convenient biomolecular interaction assay.

Zhejiang University
Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.

Jinan University
Bicyclic-fused heteroaryl or aryl compounds

Pfizer
Cyclohexyl pyridine derivative

Kissei Pharmaceutical
A class of 2,4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B.

Genentech